Does ARIXTRA Cause Off label use? 18 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 18 reports of Off label use have been filed in association with ARIXTRA. This represents 6.0% of all adverse event reports for ARIXTRA.
18
Reports of Off label use with ARIXTRA
6.0%
of all ARIXTRA reports
3
Deaths
14
Hospitalizations
How Dangerous Is Off label use From ARIXTRA?
Of the 18 reports, 3 (16.7%) resulted in death, 14 (77.8%) required hospitalization, and 1 (5.6%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ARIXTRA. However, 18 reports have been filed with the FAERS database.
What Other Side Effects Does ARIXTRA Cause?
Death (37)
Investigation (33)
Haematoma (27)
Anaemia (20)
Incorrect drug administration duration (19)
Thrombosis (17)
Haemorrhage (13)
Cerebral haemorrhage (11)
Gastrointestinal haemorrhage (11)
Neoplasm malignant (11)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which ARIXTRA Alternatives Have Lower Off label use Risk?
ARIXTRA vs ARMODAFINIL
ARIXTRA vs AROMASIN
ARIXTRA vs ARSENIC TRIOXIDE
ARIXTRA vs ARTEMETHER\LUMEFANTRINE
ARIXTRA vs ARTESUNATE